Helicobacter pylori infection and respiratory diseases: Actual data and directions for future studies

Minerva Medica

Volumn 105, Issue 1, 2014, Pages 1-8

  Adriani, A ^a   Repici, A ^b   Hickman, I ^c   Pellicano, R ^a  

^a MOLINETTE HOSPITAL   (Italy)

^b HUMANITAS CLINICAL AND RESEARCH CENTER   (Italy)

^c PRINCESS ALEXANDRA HOSPITAL   (Australia)

Author keywords

Asthma; Bronchitis; Helicobacter pylori; Respiratory disorders

Indexed keywords

CYCLOOXYGENASE 2; CYTOKINE; GASTRIN;

ARTICLE; ASTHMA; BRONCHIECTASIS; CASE CONTROL STUDY; CHRONIC BRONCHITIS; CYSTIC FIBROSIS; ERADICATION THERAPY; HELICOBACTER INFECTION; HUMAN; LUNG CANCER; LUNG SARCOIDOSIS; LUNG TUBERCULOSIS; NONHUMAN; PATHOGENESIS; PROTEIN BLOOD LEVEL; RESPIRATORY TRACT DISEASE; SEROPREVALENCE; SOCIAL STATUS; TOBACCO USE;

ASTHMA; BRONCHIECTASIS; BRONCHITIS, CHRONIC; CYSTIC FIBROSIS; HELICOBACTER INFECTIONS; HELICOBACTER PYLORI; HUMANS; LUNG DISEASES; LUNG NEOPLASMS; RESPIRATORY TRACT DISEASES; SARCOIDOSIS, PULMONARY; TUBERCULOSIS, PULMONARY;

EID: 84898445023     PISSN: 00264806     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (86)

1. Minicuci N, Benacchio L, Noale M, Campigotto F, Balzi D, Franzo A et al. Chronic obstructive pulmonary disease: the Disability Adjusted Life Years in northern Italy. Minerva Med 2011;102:1-14.
2. Santus P, Picciolo S, Proietto A, Falcone F, Mangiacavallo A, Marrocco W et al. General practitioners and management of patients with respiratory diseases in a real life survey. Panminerva Med 2012;54:293-8.
3. Stephens MB, Yew KS. Diagnosis of chronic obstructive pulmonary disease. Am Fam Physician. 2008;78:87-92.
4. Braido F, Bagnasco D, Scichilone N, Santus P, Solidoro P, Di Marco F et al. Biomarkers in obstructive respiratory diseases: an update. Panminerva Med 2012;54:119-27.
5. Murase K, Tomii K, Chin K, Niimi A, Ishihara K, Mishima M. Non-invasive ventilation in severe asthma attack, its possibilities and problems. Panminerva Med 2011;53:87-96.
6. McColl KE. Clinical practice. Helicobacter pylori infection. N Engl J Med 2010;362:1597-604.
7. Malfertheiner P, Megraud F, O'Morain C, Atherton J, Axon AT, Bazzoli F et al. Management of Helicobacter pylori infection-the Maastricht IV/Florence Consensus Report. Gut 2012;61:646-64.
8. Pellicano R, Fagoonee S, Astegiano M, Morgando A, Cisarò F, Rizzetto M. Amoxycillin plus tetracycline as first-line Helicobacter pylori treatment. Minerva Med 2011;102:169-70.
9. Güzelbulut F, Sezikli M, Akkan Çetinkaya Z, Erhan Altunöz M, Günes P, Düzgün S et al. Application of levofloxacine in the second phase of sequential therapy regimen for Helicobacter pylori eradication: is it a good choice? Minerva Med 2011;102:171-6.
10. Cennamo V, Morace C, Ceroni L, Fabbri C. On the efficacy of penicillins for Helicobacter pylori eradication. Panminerva Med 2011;53:137.
11. Cisarò F, Astegiano M, De Angelis C, Saracco G, Rizzetto M, Pellicano R. Ranitidine bismuth citrate in the first-line of Helicobacter pylori treatment. Panminerva Med 2011;53:138.
12. Fagoonee S., Pellicano R. Ampicillin-based therapy for Helicobacter pylori eradication. Panminerva Med 2011;53:261.
13. Vizzardi E, Bonadei I, Piovanelli B, Quinzani F, Ricci C, Lanzini A et al. Helicobacter pylori and ischemic heart disease. Panminerva Med 2011;53:193-202.
14. Pellicano R, Franceschi F, Saracco G, Fagoonee S, Roccarina D, Gasbarrini A. Helicobacters and extragastric diseases. Helicobacter 2009;14(Suppl 1):58-68.
15. Langman MJ, Cooke AR. Gastric and duodenal ulcer and their associated diseases. Lancet 1976;1:680-3.
16. Kellow JE, Tao Z, Piper DW. Ventilatory function in chronic peptic ulcer. Gastroenterology 1986;91:590-5.
17. Arora OP, Kapoor CP, Sobti P. Study of gastroduodenal abnormalities in chronic bronchitis and emphysema. Am J Gastroenterol 1968;50:289-96.
18. Bonnevie O. Causes of death in duodenal and gastric ulcer. Gastroenterology 1977;73:1000-4.
19. Gaselli M, Zaffoni E, Ruina M, Sartori S, Trevisani L, Ciaccia A et al. Helicobacter pylori and chronic bronchitis. Scand J Gastroenterol 1999;34.828-30.
20. Rosenstock SJ, Jorgensen T, Andersen LP, Bonnevie O. Association of Helicobacter pylori infection with lifestyle, chronic disease, body-indices, and age at menarche in Danish adults. Scand J Public Health 2000;28:32-40.
21. Jun ZJ, Lei Y, shimizu Y, Dobashi K, Mori M. High seroprevalence of Helicobacter pylori in chronic bronchitis among Chinese population. Tohoku J Exp Med 2006:208:327-31.
22. Roussos A, Philippou N, Krietsepi V, Anastasakou E, Alepopoulou D, Koursarakos P et al. Helicobacter pylori seroprevalence in patients with chronic obstructive pulmonary disease. Respir Med 2005;99:279-84.
23. Roussos A, Tsimpoukas F, Anastasakou E, Alepopoulou D, Paizis I, Philippou N. Helicobacter pylori seroprevalence in patients with chronic bronchitis. J Gastroenterol 2002;37:3325.
24. Kanbay M, Gur G, Akcay S, Yilmaz U. Helicobacter pylori seroprevalence in patients with chronic bronchitis. Respir Med 2005;99:1213-6.
25. Gencer M, Ceylan E, Yildiz Zeyrek F, Aksoy N. Helicobacter pylori seroprevalence in patients with chronic obstructive pulmonary disease and its relation to pulmonary function tests. Respiration 2007;74:170-5.
26. Siva R, Birring SS, Berry M, Rowbottom A, Pavord ID. Peptic ulceration, Helicobacter pylori seropositivity and chronic obstructive pulmonary disease. Respirology 2013;18:728-31.
27. Peterson WL, Graham DY. Helicobacter pylori. In: Feldman M, Scharschmidt BF, Sleisenger MH, editors. Gastrointestinal and liver disease. Pathophysiology, diagnosis, management. 6th ed. Philadelphia, PA: WB Saunders; 1998. p.604-19.
28. Gomez FP, Rodriguez-Roisin R. Global Initiative for Chronic Obstructive Lung Disease (GOLD) guidelines for chronic obstructive pulmonary disease. Curr Opin Pulm Med 2002;8:81-6.
29. Malfertheiner MV, Kandulski A, Schreiber J, Malfertheiner P. Helicobacter pylori Infection and the Respiratory System: A Systematic Review of the Literature. Digestion 2011;84:212-20.
30. Caramori G, Casolari P, Giuffrè S, Barczyk A, Adcock I, Papi A. COPD pathology in the small airways. Panminerva Med 2011;53:51-70.
31. Ogihara A, Kikuchi S, Hasegawa A, Kurosawa M, Miki K, Kaneko E et al. Relationship between Helicobacter pylori infection and smoking and drinking habits. J Gastroenterol Hepatol 2000;15:271-6.
32. Brenner H, Rothenbacher D, Bode G, Adler G. Relation of smoking and alcohol and coffee consumption to active Helicobacter pylori infection: cross sectional study. BMJ 1997;315:1489-92.
33. Parasher G, Eastwood GL. Smoking and peptic ulcer in the Helicobacter pylori era. Eur J Gastroenterol Hepatol 2000;12:843-53.
34. Kountouras J, Boura P, Lygidakis NJ. Omeprazole and regulation of cytokine profile in Helicobacter pylori-infected patients with duodenal ulcer disease. Hepatogastroenterology 2000;47:1301-4.
35. Huang SL, Su CH, Chang SC. Tumor necrosis factor-a gene polymorphism in chronic bronchitis. Am J Resp Crit Care Med 1997;156:1436-9.
36. Nelson S, Summer WR, Mason CM. The role of the inflammatory response in chronic bronchitis: therapeutic implications. Semin Respir Infect 2000;15:24-31.
37. Keatings VM, Collins PD, Scott DM, Barnes PJ. Differences in interleukin-8 and tumor necrosis factor-a in induced sputum from patients with chronic obstructive pulmonary disease or asthma. Am J Respir Crit Care Med 1996;153:530-4.
38. Kanazawa H, Kurihara N, Otsuka T, Fujii T, Tanaka S, Kudoh S et al. Clinical significance of serum concentration of interleukin 8 in patients with bronchial asthma or chronic pulmonary emphysema. Respiration 1996;63:236-40.
39. Schulz C, Wolf K, Harth M, Kratzel K, Kunz-Schughart L, Pfeifer M. Expression and release of interleukin-8 by human bronchial epithelial cells from patients with chronic obstructive pulmonary disease, smokers, and neversmokers. Respiration 2003;70:254-61.
40. Stemmier S, Arinir U, Klein W, Rohde G, Hoffjan S, Wirkus N et al. Association of interleukin-8 receptor alpha polymorphisms with chronic obstructive pulmonary disease and asthma. Genes Immun 2005;6:225-30.
41. Tsang KW, Lam SK, Lam WK, Karlberg J, Wong BC, Hu WH et al. High seroprevalence of Helicobacter pylori in active bronchiectasis. Am J Respir Crit Care Med 1998;158:1047-51.
42. Tsang KW, Lam WK, Kwok E, Chan KN, Hu WH, Ooi GC. Helicobacter pylori and upper gastrointestinal symptoms in bronchiectasis. Eur Respir J 1999;14:1345-50.
43. Fullerton D, Britton JR, Lewis SA, Pavord ID, McKeever TM, Fogarty AW. Helicobacter pylori and lung function, asthma, atopy and allergic disease - a population-based cross-sectional study in adults. Int J Epidemiol 2009;38:419-26.
44. Shiotani A, Miyanishi T, Kamada T, Haruma K. Helicobacter pylori infection and allergic diseases: epidemiological study in Japanese university students. J Gastroenterol Hepatol 2008;23:e29-33.
45. Reibman J, Marmor M, Filner J, Fernandez-Beros ME, Rogers L, Perez-Perez GI et al. Asthma is inversely associated with Helicobacter pylori status in an urban population. PLoS One 2008;3 e4060.
46. Chen Y, Blaser MJ. Helicobacter pylori colonization is inversely associated with childhood asthma. J Infect Dis 2008;198:553-60.
47. Janson C, Asbjornsdottir H, Birgisdottir A, Sigurjonsdottir RB, Gunnbjörnsdottir M, Gislason D et al. The effect of infectious burden on the prevalence of atopy and respiratory allergies in Iceland, Estonia, and Sweden. J Allergy Clin Immunol 2007;120:673-9.
48. Chen Y, Blaser MJ. Inverse associations of Helicobacter pylori with asthma and allergy. Arch Intern Med 2007;167:821-7.
49. Jun ZJ, Lei Y, Shimizu Y, Dobashi K, Mori M. Helicobacter pylori seroprevalence in patients with mild asthma. Tohoku J Exp Med 2005;207:287-91.
50. McCune A, Lane A, Murray L, Harvey I, Nair P, Donovan J et al. Reduced risk of atopic disorders in adults with Helicobacter pylori infection. Eur J Gastroenterol Hepatol 2003;15:637-40.
51. Tsang KW, Urn WK, Chan KN, Hu W, Wu A, Kwok E et al. Helicobacter pylori seroprevalence in asthma. Respir Med 2000;94:756-9.
52. Bodner C, Anderson VCJ, Reid TS, Godden DJ. Childhood exposure to infection and risk of adult onset wheeze and atopy. Thorax 2000;55:383-7.
53. Codolo G, Mazzi P, Amedei A, Del Prete G, Berton G, D'Elios MM et al. The neutrophil-activating protein of Helicobacter pylori down-modulates Th2 inflammation in ovalbumin-induced allergic asthma. Cell Microbiol 2008;10:2355-63.
54. Raj SM, Choo KE, Noorizan AM, Lee YY, Graham DY. Evidence against Helicobacter pylori being related to childhood asthma. J Infect Dis 2009;199:914-5.
55. International Agency for Research on Cancer. Schistosomes, liver flukes and Helicobacter pylori. IARC monographs on the evaluation of carcinogenic risks to humans, vol. 61. Lyon, France: IARC; 1994.
56. Lundegardh G, Helmick C, Zack M, Adami HO. Mortality among patients with partial gastrectomy for benign ulcer disease. Dig Dis Sci 1994;39:340-0.
57. Gocyk W, Niklinski T, Olechnowicz H, Duda A, Bielanski W, Konturek PC et al. Helicobacter pylori, gastrin and cyclooxygenase-2 in lung cancer. Med Sci Monit 2000;6:1085-92.
58. Ece F, Hatabay NF, Erdal N, Gedik C, Guney C, Aksoy F. Does Helicobacter pylori infection play a role in lung cancer? Respir Med 2005;99:1258-62.
59. Zhou Q, Zhang H, Pang X, Yang J, Tain Z, Wu Z et al. Pre- and postoperative sequential study on the serum gastrin level in patients with lung cancer. J Surg Oncol 1992;51:22-5.
60. Dowlati A, Bury T, Corhay JL, Weber T, Lamproye A, Mendes P et al. Gastrin levels in serum and bronchoalveolar lavage fluid of patients with lung cancer: comparison with patients with chronic obstructive pulmonary disease. Thorax 1996;51:1270-2.
61. Philippou N, Koursarakos P, Anastasakou E, Krietsepi V, Mavrea S, Roussos A et al. Helicobacter pylori seroprevalence in patients with lung cancer. World J Gastroenterol 2004;10:3342-4.
62. Najafizadeh K, Falah Tafti S, Shiehmorteza M, Saloor M, Jamali M. H. pylori seroprevalence in patients with lung cancer. World J Gastroenterol 2007;13:2349-51.
63. Zhou Q, Yang Z, Yang J, Tian Z, Zhang H. The diagnostic significance of gastrin measurement of bronchoalveolar lavage fluid for lung cancer. J Surg Oncol 1992;50:121-4.
64. Holmboe AM, Nissen-Meyer S. Gastroduodenal ulcer and pulmonary tuberculosis. Nord Med 1957;57:575-8.
65. Lundegardh G, Adami HO, Helmick C, Zack M. Risk of cancer following partial gastrectomy for benign ulcer disease. Br J Surg 1994;81:1164-7.
66. Filippou N, Roussos A, Tsimpoukas F, Tsimogianni A, Anastasakou E, Mavrea S. Helicobacter pylori seroprevalence in patients with pulmonary tuberculosis. J Clin Gastroenterol 2002;34:189-90.
67. Mitchell HM, Li YY, Hu PJ, Liu Q, Chen M, Du GG et al. Epidemiology of Helicobacter pylori in southern China: identification of early childhood as the critical period for acquisition. J Infect Dis 1992;166:149-53.
68. Sanaka M, Kuyama Y, Iwasaki M, Hanada Y, Tsuchiya A, Haida T et al. No difference in seroprevalences of Helicobacter pylori infection between patients with pulmonary tuberculosis and those without. J Clin Gastroenterol 1998;27:331-4.
69. Sanaka M, Kuyama Y, Yamanaka M, Iwasaki M. Decrease of serum concentrations of Helicobacter pylori IgG antibodies during antituberculosis therapy: the possible eradication by rifampicin and streptomycin. Am J Gastroenterol 1999;94:1983-4.
70. Heep M, Beck D, Bayerdorffer E, Lehn N. Rifampin and rifabutin resistance mechanisms in Helicobacter pylori. Antimicrob Agents Chemother 1999;43:1497-9.
71. Goldfeld AE, Delgado JC, Thim S, Bozon MV, Uglialoro AM, Turbay D et al. Association of an HLA-DQ allele with clinical tuberculosis. JAMA 1998;279:226-8.
72. Azuma T, Konishi J, Tanaka Y, Hirai M, Ito S, Kato T et al. Contribution of HLA-DQA gene to host's response against Helicobacter pylori. Lancet 1994;343:542-3.
73. Campello S, Tombola F, Cabrini G, Zoratti M. The vacuolating toxin of Helicobacter pylori mimicks the CFTR-mediated chloride conductance. FEBS Lett 2002;532:237-40.
74. Israel NR, Khanna B, Cutler A, Perry M, Caplan D, Weatherly M et al. Seroprevalence of Helicobacter pylori infection in cystic fibrosis and its cross-reactivity with anti-pseudomonas antibodies. J Pediatr Gastroenterol Nutr 2000;30:426-31.
75. Lubani MM, al-Saleh QA, Teebi AS, Moosa A, Kalaoui MH. Cystic fibrosis and Helicobacter pylori gastritis, megaloblastic anaemia, subnormal mentality and minor anomalies in two siblings: a new syndrome? Eur J Pediatr 1991;150:253-5.
76. Yahav J, Samra Z, Blau H, Dinari G, Chodick G, Shmuely H. Helicobacter pylori and Clostridium difficile in cystic fibrosis patients. Dig Dis Sci 2006;51:2274-9.
77. Johansen HK, Nørgaard A, Andersen LP, Jensen P, Nielsen H, Høiby N. Cross-reactive antigens shared by Pseudomonas aeruginosa, Helicobacter pylori, Campylobacter jejuni, and Haemophilus influenzae may cause falsepositive titers of antibody to H. pylori. Clin Diagn Lab Immunol 1995;2:149-55.
78. Rossman MD, Kreider ME. Lesson learned from ACCESS (A Case Controlled Etiologic Study of Sarcoidosis). Proc Am Thorac Soc 2007;4:453-6.
79. Pope JB, Danford JR. Symptomatic gastric sarcoidosis and Helicobacter pylori infection. J Am Board Fam Pract 1996;9:451-4.
80. Buciuto R, Kullman E, Boeryd B, Borch K. Helicobacter pylori gastritis associated with a gastric inflammatory fibroid tumour and sarcoidosis. Eur J Surg 1996;162:421-4.
81. Herndon BL, Vlach V, Dew M, Willsie SK. Helicobacter pylori-related immunoglobulins in sarcoidosis. J Investig Med 2004;52.137-43.
82. Koyama S, Nagashima F. Idiopathic granulomatous gastritis with multiple aphthoid ulcers. Intern Med 2003;42:691-5.
83. Renault M, Goodier A, Subramony C, Hood B, Bishop P, Nowicki M. Age-related differences in granulomatous gastritis: a retrospective, clinicopathological analysis. J Clin Pathol 2010;63:347-50.
84. Schulz KF, Grimes DA. Sample size calculations in randomized trials: mandatory and mystical. Lancet 2005;365:1348-53.
85. Lowe AM, Yansouni CP, Behr MA. Causality and gastrointestinal infections: Koch, Hill, and Crohn's. Lancet Infect Dis 2008;8:720-6.
86. Pellicano R, Fagoonee S. On Helicobacter pylori seropositivity in patients with chronic obstructive pulmonary disease. Respirology 2013;18:887.